Dr. Lal PathLabs [LALPATHLAB] vs Vijaya Diagnostic [VIJAYA] Detailed Stock Comparison

Dr. Lal PathLabs Ltd.

NSE
Loading...

Vijaya Diagnostic Centre Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr. Lal PathLabs Ltd. wins in 13 metrics, Vijaya Diagnostic Centre Ltd. wins in 7 metrics, with 0 ties. Dr. Lal PathLabs Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dr. Lal PathLabs Ltd. Vijaya Diagnostic Centre Ltd. Better
P/E Ratio (TTM) 46.16 67.41 Dr. Lal PathLabs Ltd.
Price-to-Book Ratio 10.20 12.37 Dr. Lal PathLabs Ltd.
Debt-to-Equity Ratio 6.44 42.22 Dr. Lal PathLabs Ltd.
PEG Ratio -7.05 25.06 Vijaya Diagnostic Centre Ltd.
EV/EBITDA 32.00 39.80 Dr. Lal PathLabs Ltd.
Profit Margin (TTM) 19.84% 20.73% Vijaya Diagnostic Centre Ltd.
Operating Margin (TTM) 20.79% 30.07% Vijaya Diagnostic Centre Ltd.
EBITDA Margin (TTM) 20.79% 30.07% Vijaya Diagnostic Centre Ltd.
Return on Equity 22.08% 17.90% Dr. Lal PathLabs Ltd.
Return on Assets (TTM) 17.93% 11.23% Dr. Lal PathLabs Ltd.
Free Cash Flow (TTM) $5.15B $1.29B Dr. Lal PathLabs Ltd.
Dividend Yield 1.56% 0.30% Dr. Lal PathLabs Ltd.
1-Year Return 8.45% 35.44% Vijaya Diagnostic Centre Ltd.
Price-to-Sales Ratio (TTM) 9.15 13.94 Dr. Lal PathLabs Ltd.
Enterprise Value $228.83B $107.20B Dr. Lal PathLabs Ltd.
EV/Revenue Ratio 8.59 13.96 Dr. Lal PathLabs Ltd.
Gross Profit Margin (TTM) 65.97% 88.29% Vijaya Diagnostic Centre Ltd.
Revenue per Share (TTM) $160 $75 Dr. Lal PathLabs Ltd.
Earnings per Share (Diluted) $31.61 $15.44 Dr. Lal PathLabs Ltd.
Beta (Stock Volatility) 0.10 0.01 Vijaya Diagnostic Centre Ltd.

Dr. Lal PathLabs Ltd. vs Vijaya Diagnostic Centre Ltd. Stock Performance Analysis

Loading Price Chart...

LALPATHLAB
VIJAYA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr. Lal PathLabs Ltd.0.91%4.53%0.82%20.51%13.04%7.03%
Vijaya Diagnostic Centre Ltd.-0.31%-1.87%-3.46%36.74%29.74%23.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr. Lal PathLabs Ltd.8.45%58.06%0.84%257.00%257.46%257.46%
Vijaya Diagnostic Centre Ltd.35.44%216.81%105.30%105.30%105.30%105.30%

Performance & Financial Health Analysis: Dr. Lal PathLabs Ltd. vs Vijaya Diagnostic Centre Ltd.

MetricLALPATHLABVIJAYA
Market Information
Market Cap i₹238.92B₹109.64B
Market Cap CategoryLarge capMid cap
10 Day Avg. Volume i392,728111,888
90 Day Avg. Volume i321,187123,950
Last Close₹1,616.00₹1,283.20
52 Week Range₹1,272.60 - ₹1,770.00₹848.00 - ₹1,427.80
% from 52W High-8.70%-10.13%
All-Time High₹4,245.50 (Sep 13, 2021)₹1,427.80 (Jun 05, 2026)
% from All-Time High-61.94%-10.13%
Growth Metrics
Quarterly Revenue Growth0.11%0.21%
Quarterly Earnings Growth-0.06%0.23%
Financial Health
Profit Margin (TTM) i0.20%0.21%
Operating Margin (TTM) i0.21%0.30%
Return on Equity (TTM) i0.22%0.18%
Debt to Equity (MRQ) i6.4442.22
Cash & Liquidity
Book Value per Share (MRQ)₹143.09₹84.14
Cash per Share (MRQ)₹77.96₹28.88
Operating Cash Flow (TTM) i₹4.66B₹2.04B
Levered Free Cash Flow (TTM) i₹4.87B₹1.43B
Dividends
Last 12-Month Dividend Yield i1.56%0.30%
Last 12-Month Dividend i₹22.50₹3.00

Valuation & Enterprise Metrics Analysis: Dr. Lal PathLabs Ltd. vs Vijaya Diagnostic Centre Ltd.

MetricLALPATHLAB (Apr 24, 2026)VIJAYA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i46.1667.41
Forward P/E i41.2350.66
PEG Ratio i-7.0525.06
Price to Sales (TTM) i9.1513.94
Price to Book (MRQ) i10.2012.37
Market Capitalization
Market Capitalization i₹238.92B₹109.64B
Enterprise Value i₹228.83B₹107.20B
Enterprise Value Metrics
Enterprise to Revenue i8.5913.96
Enterprise to EBITDA i32.0039.80
Risk & Other Metrics
Beta i0.100.01
Book Value per Share (MRQ) i₹143.09₹84.14

Financial Statements Comparison: Dr. Lal PathLabs Ltd. vs Vijaya Diagnostic Centre Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLALPATHLAB (2025)VIJAYA (2025)
Revenue/Sales i24.61B6.81B
Cost of Goods Sold i8.23B847.64M
COGS % of Revenue i33.4%12.4%
Gross Profit i16.38B5.96B
Gross Margin i66.6%87.6%
Research & Development iN/AN/A
Operating Income (EBIT) i5.60B2.03B
Operating Margin i22.8%29.8%
EBITDA i7.74B2.77B
EBITDA Margin i31.5%40.7%
Pre-Tax Income i6.25B1.93B
Pre-Tax Income % of Revenue i25.4%28.4%
Income Tax i1.33B493.71M
Income Tax % of Revenue i5.4%7.3%
Net Income (Profit) i4.92B1.44B
Profit Margin i20.0%21.1%

Balance Sheet & Liquidity Metrics

MetricLALPATHLAB (2025)VIJAYA (2025)
Cash & Equivalents i2.93B127.94M
Total Current Assets i13.64B3.07B
Total Current Assets % of Revenue i55.4%45.1%
Total Current Liabilities i4.02B1.63B
Total Current Liabilities % of Revenue i16.3%23.9%
Long-Term Debt i1.03B2.96B
Long-Term Debt % of Revenue i4.2%43.5%
Total Shareholders Equity i22.06B7.99B
Retained Earnings i18.60B7.21B
Retained Earnings % of Revenue i75.6%105.9%
Property, Plant & Equipment i3.36B314.88M

Cash Flow Statement Comparison

MetricLALPATHLAB (2025)VIJAYA (2025)
Operating Cash Flow i4.66B2.04B
Operating Cash Flow % of Revenue i18.9%30.0%
Capital Expenditures i-436.20M-926.14M
Free Cash Flow i5.15B1.29B
FCF Margin i20.9%18.9%
Debt Repayment i-833.34MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLALPATHLABVIJAYA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i166.97M102.90M
Float Shares i75.55M48.82M
% Held by Insiders i54.91%52.51%
% Held by Institutions i31.54%34.14%
% Held by Public i13.55%13.35%

Dividend Analysis & Yield Comparison: Dr. Lal PathLabs Ltd. vs Vijaya Diagnostic Centre Ltd.

MetricLALPATHLABVIJAYA
Last 12-Month Dividend i₹22.50₹3.00
Last 12-Month Dividend Yield i1.56%0.30%
3-Year Avg Annual Dividend i₹23.50₹1.67
3-Year Avg Dividend Yield i0.51%0.19%
3-Year Total Dividends i₹70.50₹5.00
Ex-Dividend DateFeb 05, 2026Aug 29, 2025